Dirlotapide

DB11399InvestigationalVet approvedSmall molecule

Dirlotapide is a drug employed in the treatment of obesity in dogs. It is marketed by Pfizer and Zoetis under the brand name, Slentrol, and is not intended for human...

Formula / weight: C₄₀H₃₃F₃N₄O₃ · 674.724 g/mol (avg)
Code names: CP-742,033

Resolves to

Compound

UNII578H0RMP25CAS481658-94-0ChEMBLCHEMBL410414KEGGD03867

Clinical / RWD

RxNorm1592684

Structure

InChIKeyTUOSYWCFRFNJBS-BHVANESWSA-NSMILESCN(CC1=CC=CC=C1)C(=O)[C@@H](NC(=O)C1=CC2=C(C=CC(NC(=O)C3=CC=CC=C3C3=CC=C(C=C3)C(F)(F)F)=C2)N1C)C1=CC=CC=C1

Targets

P55157MTTP

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

11+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dirlotapide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account